Smith, W. L.; Song, I (2002). “The enzymology of prostaglandin endoperoxide H synthases-1 and -2”. 《Prostaglandins & other lipid mediators》. 68–69: 115–28. doi:10.1016/s0090-6980(02)00025-4. PMID12432913.
Zhu, D; Ran, Y (May 2012). “Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension”. 《J Physiol Sci》 62 (3): 163–72. doi:10.1007/s12576-012-0196-9. PMID22331435.
Romano, M; Cianci, E; Simiele, F; Recchiuti, A (Aug 2015). “Lipoxins and aspirin-triggered lipoxins in resolution of inflammation”. 《Eur J Pharmacol》 760: 49–63. doi:10.1016/j.ejphar.2015.03.083. PMID25895638.
Porro, B; Songia, P; Squellerio, I; Tremoli, E; Cavalca, V (Aug 2014). “Analysis, physiological and clinical significance of 12-HETE: A neglected platelet-derived 12-lipoxygenase product”. 《J Chromatogr B》 964: 26–40. doi:10.1016/j.jchromb.2014.03.015. PMID24685839.
Ueda, Natsuo; Tsuboi, Kazuhito; Uyama, Toru (May 2013). “Metabolism of endocannabinoids and related N -acylethanolamines: Canonical and alternative pathways”. 《FEBS J.》 280 (9): 1874–94. doi:10.1111/febs.12152. PMID23425575.
Birch, Eileen E; Garfield, Sharon; Hoffman, Dennis R; Uauy, Ricardo; Birch, David G (2007). “A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants”. 《Developmental Medicine & Child Neurology》 42 (3): 174–181. doi:10.1111/j.1469-8749.2000.tb00066.x.
Amtul, Z.; Uhrig, M.; Wang, L.; Rozmahel, R. F.; Beyreuther, K. (2012). “Detrimental effects of arachidonic acid and its metabolites in cellular and mouse models of Alzheimer's disease: Structural insight”. 《Neurobiology of Aging》 33 (4): 831.e21–31. doi:10.1016/j.neurobiolaging.2011.07.014. PMID21920632.
Schaeffer, EL; Forlenza, OV; Gattaz, WF (2009). “Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease”. 《Psychopharmacology》 202 (1–3): 37–51. doi:10.1007/s00213-008-1351-0. PMID18853146.
Calderón-Garcidueñas, L; Reed, W; Maronpot, R. R.; Henríquez-Roldán, C; Delgado-Chavez, R; Calderón-Garcidueñas, A; Dragustinovis, I; Franco-Lira, M; Aragón-Flores, M; Solt, A. C.; Altenburg, M; Torres-Jardón, R; Swenberg, J. A. (2004). “Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution”. 《Toxicologic Pathology》 32 (6): 650–8. doi:10.1080/01926230490520232. PMID15513908.
Harris, WS; Mozaffarian, D; Rimm, E; Kris-Etherton, P; Rudel, LL; Appel, LJ; Engler, MM; Engler, MB; Sacks, F (2009). “Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention”. 《Circulation》 119 (6): 902–7. doi:10.1161/CIRCULATIONAHA.108.191627. PMID19171857.
Nelson, GJ; Schmidt, PC; Bartolini, G; Kelley, DS; Kyle, D (1997). “The effect of dietary arachidonic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans”. 《Lipids》 32 (4): 421–5. doi:10.1007/s11745-997-0055-7. PMID9113631.
Pantaleo, P; Marra, F; Vizzutti, F; Spadoni, S; Ciabattoni, G; Galli, C; La Villa, G; Gentilini, P; Laffi, G (2004). “Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis”. 《Clinical Science》 106 (1): 27–34. doi:10.1042/CS20030182. PMID12877651.
Ferrucci, L; Cherubini, A; Bandinelli, S; Bartali, B; Corsi, A; Lauretani, F; Martin, A; Andres-Lacueva, C; Senin, U; Guralnik, JM (2006). “Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers”. 《The Journal of Clinical Endocrinology and Metabolism》 91 (2): 439–46. doi:10.1210/jc.2005-1303. PMID16234304.
Nelson, GJ; Schmidt, PC; Bartolini, G; Kelley, DS; Phinney, SD; Kyle, D; Silbermann, S; Schaefer, EJ (1997). “The effect of dietary arachidonic acid on plasma lipoprotein distributions, apoproteins, blood lipid levels, and tissue fatty acid composition in humans”. 《Lipids》 32 (4): 427–33. doi:10.1007/s11745-997-0056-6. PMID9113632.
Borkman, M; Storlien, LH; Pan, DA; Jenkins, AB; Chisholm, DJ; Campbell, LV (1993). “The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids”. 《The New England Journal of Medicine》 328 (4): 238–44. doi:10.1056/NEJM199301283280404. PMID8418404.
Wlodawer, P; Samuelsson, B (1973). “On the organization and mechanism of prostaglandin synthetase”. 《The Journal of Biological Chemistry》 248 (16): 5673–8. PMID4723909.
Smith, W. L.; Song, I (2002). “The enzymology of prostaglandin endoperoxide H synthases-1 and -2”. 《Prostaglandins & other lipid mediators》. 68–69: 115–28. doi:10.1016/s0090-6980(02)00025-4. PMID12432913.
Zhu, D; Ran, Y (May 2012). “Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension”. 《J Physiol Sci》 62 (3): 163–72. doi:10.1007/s12576-012-0196-9. PMID22331435.
Romano, M; Cianci, E; Simiele, F; Recchiuti, A (Aug 2015). “Lipoxins and aspirin-triggered lipoxins in resolution of inflammation”. 《Eur J Pharmacol》 760: 49–63. doi:10.1016/j.ejphar.2015.03.083. PMID25895638.
Porro, B; Songia, P; Squellerio, I; Tremoli, E; Cavalca, V (Aug 2014). “Analysis, physiological and clinical significance of 12-HETE: A neglected platelet-derived 12-lipoxygenase product”. 《J Chromatogr B》 964: 26–40. doi:10.1016/j.jchromb.2014.03.015. PMID24685839.
Ueda, Natsuo; Tsuboi, Kazuhito; Uyama, Toru (May 2013). “Metabolism of endocannabinoids and related N -acylethanolamines: Canonical and alternative pathways”. 《FEBS J.》 280 (9): 1874–94. doi:10.1111/febs.12152. PMID23425575.
Crawford, MA; Sinclair, AJ (1971). “Nutritional influences in the evolution of mammalian brain. In: lipids, malnutrition & the developing brain”. 《Ciba Foundation symposium》: 267–92. PMID4949878.
Amtul, Z.; Uhrig, M.; Wang, L.; Rozmahel, R. F.; Beyreuther, K. (2012). “Detrimental effects of arachidonic acid and its metabolites in cellular and mouse models of Alzheimer's disease: Structural insight”. 《Neurobiology of Aging》 33 (4): 831.e21–31. doi:10.1016/j.neurobiolaging.2011.07.014. PMID21920632.
Schaeffer, EL; Forlenza, OV; Gattaz, WF (2009). “Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease”. 《Psychopharmacology》 202 (1–3): 37–51. doi:10.1007/s00213-008-1351-0. PMID18853146.
Calderón-Garcidueñas, L; Reed, W; Maronpot, R. R.; Henríquez-Roldán, C; Delgado-Chavez, R; Calderón-Garcidueñas, A; Dragustinovis, I; Franco-Lira, M; Aragón-Flores, M; Solt, A. C.; Altenburg, M; Torres-Jardón, R; Swenberg, J. A. (2004). “Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution”. 《Toxicologic Pathology》 32 (6): 650–8. doi:10.1080/01926230490520232. PMID15513908.
Harris, WS; Mozaffarian, D; Rimm, E; Kris-Etherton, P; Rudel, LL; Appel, LJ; Engler, MM; Engler, MB; Sacks, F (2009). “Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention”. 《Circulation》 119 (6): 902–7. doi:10.1161/CIRCULATIONAHA.108.191627. PMID19171857.
Nelson, GJ; Schmidt, PC; Bartolini, G; Kelley, DS; Kyle, D (1997). “The effect of dietary arachidonic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans”. 《Lipids》 32 (4): 421–5. doi:10.1007/s11745-997-0055-7. PMID9113631.
Pantaleo, P; Marra, F; Vizzutti, F; Spadoni, S; Ciabattoni, G; Galli, C; La Villa, G; Gentilini, P; Laffi, G (2004). “Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis”. 《Clinical Science》 106 (1): 27–34. doi:10.1042/CS20030182. PMID12877651.
Ferrucci, L; Cherubini, A; Bandinelli, S; Bartali, B; Corsi, A; Lauretani, F; Martin, A; Andres-Lacueva, C; Senin, U; Guralnik, JM (2006). “Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers”. 《The Journal of Clinical Endocrinology and Metabolism》 91 (2): 439–46. doi:10.1210/jc.2005-1303. PMID16234304.
Borkman, M; Storlien, LH; Pan, DA; Jenkins, AB; Chisholm, DJ; Campbell, LV (1993). “The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids”. 《The New England Journal of Medicine》 328 (4): 238–44. doi:10.1056/NEJM199301283280404. PMID8418404.
Leitzmann, MF; Stampfer, MJ; Michaud, DS; Augustsson, K; Colditz, GC; Willett, WC; Giovannucci, EL (2004). “Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer”. 《The American Journal of Clinical Nutrition》 80 (1): 204–16. PMID15213050.
Astorg, P (2005). “Dietary fatty acids and colorectal and prostate cancers: epidemiological studies”. 《Bulletin du cancer》 92 (7): 670–84. PMID16123006.
Whelan, J; McEntee, MF (2004). “Dietary (n-6) PUFA and intestinal tumorigenesis”. 《The Journal of Nutrition》 134 (12 Suppl): 3421S–3426S. PMID15570048.